Ignite Creation Date:
2024-05-05 @ 9:59 PM
Last Modification Date:
2024-10-26 @ 10:12 AM
Study NCT ID:
NCT01008150
Status:
COMPLETED
Last Update Posted:
2021-10-25
First Post:
2009-11-03
Brief Title:
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib andor Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Sponsor:
Organization:
NSABP Foundation Inc